InvestorsHub Logo
Followers 240
Posts 12161
Boards Moderated 0
Alias Born 08/14/2003

Re: mike00h post# 662774

Tuesday, 01/09/2024 6:07:54 PM

Tuesday, January 09, 2024 6:07:54 PM

Post# of 692400
Mike,

I believe you've got it all wrong. You're right that DCVax-L may be used with the cancers their products are aimed at, but you're wrong about those therapeutics not being needed. If those products improve survival, along with DCVax-L, they will be approved and used. It's very possible they'll replace other products, but the point is they're putting more and better tools in the Drs. tool kits.

In some cancers we're probably curing nearly everyone who have it discovered in a reasonable timeframe, those cancers probably won't get DCVax-L, or any of these new drugs. In so many others, the current benefits are clearly not that good, DCVax-L will help, and so will some of the new drugs you're citing that are under development. Curing cancer is like solving a big puzzle, DCVax's may be one of the pieces, but many other pieces are needed to solve the puzzle.

Remember, for each additional day, week, month or year that a patient lives because of DCVax's, that's also so much longer for them to purchase products from the BP's. The BP's make far more than high priced oncology drugs, your toothpaste is probably made by one of them as well. Of course if their high price oncology drugs work with the DCVax's, they'll sell a lot more of it because the patients living longer, and the treatment is used much longer.

Sure, in time one or more of these BP's may want to purchase the company, we should all be wealthy by the time that happens, if it ever does.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News